Responses
Infectious diseases
Original research
On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
Compose a Response to This Article
Other responses
No responses have been published for this article.